12 results on '"Artuc, Metin"'
Search Results
2. Human Mast Cells in the Neurohormonal Network: Expression of POMC, Detection of Precursor Proteases, and Evidence for IgE-Dependent Secretion of α-MSH.
- Author
-
Artuc, Metin, Böhm, Markus, Grützkau, Andreas, Smorodchenko, Alina, Zuberbier, Torsten, Luger, Thomas, and Henz, Beate M.
- Subjects
- *
MAST cells , *NEUROHORMONES , *PROOPIOMELANOCORTIN , *PEPTIDES , *AMINO acids , *PROTEOLYTIC enzymes - Abstract
Human mast cells have been shown to release histamine in response to the neuropeptide α-melanocyte-stimulating hormone (α-MSH), but it is unknown whether these cells express proopiomelanocortin (POMC) or POMC-derived peptides. We therefore examined highly purified human skin mast cells and a leukemic mast cell line-1 (HMC-1) for their ability to express POMC and members of the prohormone convertase (PC) family known to process POMC. Furthermore, we investigated whether these cells store and secrete α-MSH. Reverse transcriptase-PCR (RT-PCR) analysis revealed that both skin mast cells and HMC-1 cells express POMC mRNA and protein. Expression of the POMC gene at the RNA level in HMC-1 cells could be confirmed by Northern blotting. Transcripts for both PC1 and furin convertase were detectable in skin-derived mast cells and HMC-1 cells, as shown by RT-PCR. In contrast, PC2 transcripts were detected only in skin mast cells, whereas transcripts for paired basic amino acid converting enzyme 4 (PACE4) were present only in HMC-1 cells. Radioimmunoassays performed on cell lysates and cell culture supernatants from human skin-derived mast cells disclosed immunoreactive amounts of α-MSH in both fractions. Stimulation with an anti-IgE antibody significantly reduced intracellular α-MSH and increased extracellular levels, indicating IgE-mediated secretion of this neuropeptide. Our findings show that human mast cells are active players in the cutaneous POMC system. Mast cell-derived α-MSH may contribute to cutaneous hyperpigmentation as seen in patients with urticaria pigmentosa. Moreover, IgE-dependent release of α-MSH suggests an immunomodulatory role of this neurohormone during inflammatory and allergic reactions of the skin.Journal of Investigative Dermatology (2006) 126, 1976–1981. doi:10.1038/sj.jid.5700318; published online 4 May 2006 [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
3. Functional Characterization and Expression Analysis of the Proteinase-Activated Receptor-2 in Human Cutaneous Mast Cells.
- Author
-
Moormann, Corinna, Artuc, Metin, Pohl, Elena, Varga, Georg, Buddenkotte, Jörg, Vergnolle, Nathalie, Brehler, Randolf, Henz, Beate M., Schneider, Stefan W., Luger, Thomas A., and Steinhoff, Martin
- Subjects
- *
PROTEINASES , *MAST cells , *CONNECTIVE tissue cells , *CUTANEOUS glands , *CELL lines , *TRYPSIN - Abstract
Proteinase-activated receptor-2 (PAR2) belongs to a new G protein-coupled receptor subfamily activated by serine proteinases. PAR2 has been demonstrated to play a role during inflammation and immune response in different tissues including the skin. We examined whether PAR2 is functionally expressed by cutaneous human primary skin mast cells (HPMC) and the human mast cell line 1 (HMC-1). Reverse transcription-polymerase chain reaction and FACS analysis show expression of PAR2 both at the RNA and protein level. HPMCs and HMC-1 also express PAR1, PAR3, and PAR4. Ca-mobilization studies demonstrate functional PAR2 expressed by human skin mast cells, as shown by natural and synthetic PAR2 agonists. PAR2 agonists induced histamine release from HPMC indicating a role of PAR2 in regulating inflammatory and immune responses by skin mast cells. Double-immunofluorescence staining reveals colocalization of PAR2 with tryptase in the majority of human skin mast cells. In conclusion, trypsin and tryptase as well as specific agonists for PAR2 were able to induce Ca2+ mobilization in HPMCs, and agonists of PAR2 induce the release of histamine from these cells. Thus, PAR2 may be an important regulator of skin mast cell function during cutaneous inflammation and hypersensitivity.Journal of Investigative Dermatology (2006) 126, 746–755. doi:10.1038/sj.jid.5700169; published online 9 February 2006 [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
4. Human Skin Mast Cells Express H2 and H4, but not H3 Receptors.
- Author
-
Lippert, Undine, Artuc, Metin, Grutzkau, Andreas, Babina, Magda, Guhl, Sven, Haase, Ingo, Blaschke, Volker, Zachmann, Karolin, Knosalla, Marcel, Middel, Peter, Kruger-Krasagakis, Sabine, and Henzt, Beate M.
- Subjects
- *
MAST cells , *HISTAMINE , *BIOGENIC amines , *IMIDAZOLES , *IMMUNOLOGY , *IMMUNOHISTOCHEMISTRY - Abstract
Mast cells generate and release histamine during anaphylactic reactions, and there is pharmacological evidence that histamine regulates this process via specific receptors. Therefore, we examined human leukemic (HMC-1) and normal skin mast cells for the expression of all four currently known histamine receptors. Both cell types expressed H2 and H4 receptors at mRNA and protein levels, whereas H3 receptor specific mRNA and receptor protein was undetectable. Similarly, immunohistochemistry of cutaneous tissue showed an absence of H3 receptor in these cells. Despite transcription of mRNA, H1 receptor protein was only moderately expressed in HMC-1 cells and was virtually absent in skin mast cells. Furthermore, only H1, H2, and H4 receptors were detectable by Western blot analysis of HMC-1 cells. Radiolabeled histamine binding was strongly inhibited only by H2 (ranitidine)- and H3/H4 (FUB 108)-specific antagonists. Histamine-induced increase of cAMP was inhibited by the H2 receptor antagonist famotidine, whereas induction of IP3 was not observed, making signaling via the H1 receptor unlikely. These data show that human mast cells constitutively express primarily H2 and H4 receptors and that H2 receptors are functionally linked to cellular processes. They provide new insights into the mechanisms that govern auto- and paracrine histamine-induced mast cell functions. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
5. A Long-Term Coculture Model for the Study of Mast Cell–Keratinocyte Interactions.
- Author
-
Artuc, Metin, Steckelings, U. Muscha, Grützkau, Andreas, Smorodchenko, A., and Henz, Beate M.
- Subjects
- *
MAST cells , *KERATINOCYTES - Abstract
Physiologic and pathologic events associated with cutaneous differentiation and repair are the result of a concerted action of various types of resident tissue cells. In vitro models simulating this complex in vivo situation are therefore needed to clarify the specific contribution and relevant interaction of, for example, dermal mast cells with other major cutaneous cells. The aim of this study was to establish a long-term coculture model that includes dermal mast cells, dermal fibroblasts, and keratinocytes in a human skin equivalent organotypic setting. Normal dermal mast cells and fibroblasts (1:4) were enclosed in collagen gel and normal keratinocytes were grown on top with exposure to the air interface. Under these conditions, mast cell integrity and functionality was preserved even after 4 wk of culture, as shown by electron microscopy and immunohistochemistry using antibodies against the mast-cell-specific granule enzyme tryptase and the receptors for stem cell factor and IgE. Mast cells also released histamine on stimulation with anti-IgE, and on ultrastructure were found to degranulate, with decrease of granule matrix density and formation of cell-cell contacts with fibroblasts. After 2 wk of culture, keratinocytes had formed an epidermis-like multilayer and were able to proliferate and differentiate, as shown by bromodeoxyuridine incorporation of basal cells and immunohistochemical staining for transglutaminase and cytokeratins 1 and 10. The model presented here thus provides a potentially relevant tool to further clarify the interaction of dermal mast cells with major other skin cells and their contribution to cutaneous physiology, repair processes, and pathology. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
6. Mast Cell-Fibroblast Interactions: Human Mast Cells as Source and Inducers of Fibroblast and Epithelial Growth Factors.
- Author
-
Artuc, Metin, Steckelings, U. Muscha, and Henz, Beate M
- Subjects
- *
MAST cells , *GROWTH factors - Abstract
As mast cells have been implicated in cutaneous repair processes, we have examined the ability of human mast cells to produce important epithelial and fibroblast growth factors or to stimulate the production of such factors in dermal fibroblasts. Isolated, highly purified human dermal mast cells and human leukemic mast cells were examined for mRNA and partly also for protein expression of these molecules as such or after preincubation with interleukin-4, stem cell factor, or with phorbol myristate acetate. In addition, mast cells were studied for their ability to induce fibroblast growth factor 2 and fibroblast growth factor 7 secretion from dermal fibroblasts. Both dermal and leukemic mast cells expressed fibroblast growth factor 2, fibroblast growth factor 7, and heparin-binding epidermal growth factor, but not hepatocyte growth factor at mRNA level, and dermal mast cells expressed fibroblast growth factor 10 in addition. At protein level, spontaneous fibroblast growth factor 2 secretion was noted that was markedly enhanced by phorbol myristate acetate, whereas no fibroblast growth factor 7 protein was detected under these conditions. Instead, human mast cell-1 supernatants induced enhanced fibroblast growth factor 7 secretion from dermal fibroblasts, with phorbol-myristate-acetate-stimulated supernatants being more effective. This effect could be reproduced with histamine and was H1-receptor mediated. Tryptase was ineffective but stimulated instead fibroblast growth factor 2 secretion from fibroblasts. These data demonstrate for the first time the ability of mast cells to express and/or secrete several growth factors of the fibroblast growth factor family as well as heparin-binding epidermal growth factor directly or indirectly via stimulation of fibroblasts, underlining the potentially pivotal role of these cells during human tissue repair and homeostasis. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
7. Miltefosine Inhibits Human Mast Cell Activation and Mediator Release Both In Vitro and In Vivo.
- Author
-
Weller, Karsten, Artuc, Metin, Jennings, Gary, Friedrichson, Tim, Guhl, Sven, dos Santos, Rosaly V., Sünder, Cathleen, Zuberbier, Torsten, and Maurer, Marcus
- Subjects
- *
LETTERS to the editor , *MAST cells - Abstract
A letter to the editor is presented about the ability of miltefosine to inhibit human mast cell activation and mediator release both in vitro and in vivo.
- Published
- 2009
- Full Text
- View/download PDF
8. Retinoic acid potentiates inflammatory cytokines in human mast cells: Identification of mast cells as prominent constituents of the skin retinoid network.
- Author
-
Babina, Magda, Guhl, Sven, Motakis, Efthymios, Artuc, Metin, Hazzan, Tarek, Worm, Margitta, Forrest, Alistair R.R., and Zuberbier, Torsten
- Subjects
- *
TRETINOIN , *CYTOKINES , *MAST cells , *RETINOIC acid receptors , *VITAMIN A metabolism , *HOMEOSTASIS - Abstract
Retinoic acid (RA), the active vitamin-A-metabolite, has well-established functions in skin homeostasis and in the immune system. Skin mast cells (MCs) combine traits of both structures, being of hematopoietic origin, but functional in the skin environment. It remains largely unknown whether mature MCs are targeted by the retinoid network. Here, we demonstrate that human skin MCs display substantial susceptibility to RA by which they are instructed to increase pro-inflammatory mediators (IL-1β, IL-8, TNF-α) but not histamine release. The effects are observed at physiological RA levels, in different microenvironments, and are largely donor-independent. RA susceptibility is owed to the cells' abundant expression of RARA, the receptor mediating MC cytokine responses. Unexpectedly, bioinformatics calculations on the FANTOM5 expression atlas revealed general enrichment of retinoid network components in MCs against other skin cells, and MCs rapidly upregulated RA responsive genes. In conclusion, MCs are important yet hitherto overlooked retinoid targets in the skin. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
9. Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components
- Author
-
Kaschina, Elena, Scholz, Hans, Steckelings, U. Muscha, Sommerfeld, Manuela, Kemnitz, Ulrich Rudolf, Artuc, Metin, Schmidt, Sven, and Unger, Thomas
- Subjects
- *
ATHEROSCLEROSIS , *AORTIC aneurysms , *RENIN-angiotensin system , *GENE expression , *ANGIOTENSIN II , *CELL receptors , *IMMUNOBLOTTING , *IMMUNOHISTOCHEMISTRY - Abstract
Abstract: While the renin-angiotensin system (RAS) is widely recognized to be involved in atherosclerosis, its potential role in the progression from atherosclerotic lesions to abdominal aortic aneurysm (AAA) is poorly understood. The present study aimed to investigate which components of the RAS may render the atherosclerotic aorta aneurysmatic. The expression of renin, prorenin/renin receptor, angiotensinogen, AT1- and AT2 receptors, cathepsin D, cathepsin G and chymase was examined by immunoblotting and immunohistochemistry in human atherosclerotic, aneurysmatic and healthy aortic tissues obtained from patients undergoing elective repair or at autopsy. AT1- and AT2 receptor mRNA expression was determined using quantitative real-time RT-PCR. All investigated local RAS components were up-regulated in atherosclerotic as compared to healthy tissues. AAA compared to atherosclerosis was characterized by a further increase in the expression of all RAS components except for the AT2 receptor. Cathepsin D was exclusively up-regulated in AAA. Most RAS components co-localized with infiltrating leukocytes or mast cells pointing to their contribution to inflammatory processes. Due to their proteolytic features, some RAS components (cathepsin D and cathepsin G and chymase) may contribute to AAA formation by accessory mechanisms. Taken together, our data suggest that in humans, RAS activation is not just a key-player in the pathogenesis of atherosclerosis, but that a further increasing activation may be involved in the transition from atherosclerosis to AAA. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
10. PPARδ Enhances Keratinocyte Proliferation in Psoriasis and Induces Heparin-Binding EGF-Like Growth Factor.
- Author
-
Romanowska, Malgorzata, al Yacoub, Nadya, Seidel, Henrik, Donandt, Susanne, Gerken, Hannah, Phillip, Sandra, Haritonova, Nathalie, Artuc, Metin, Schweiger, Susann, Sterry, Wolfram, and Foerster, John
- Subjects
- *
PEROXISOMES , *KERATINOCYTES , *CELL proliferation , *PSORIASIS , *HEPARIN , *EPIDERMAL growth factor , *SKIN diseases , *GENE expression - Abstract
Psoriasis is a common skin disease involving keratinocyte proliferation and altered differentiation, as well as T-cell activation. Here, we show that altered gene transcription in psoriatic skin lesions is highly reproducible between independent data sets. Analysis of gene expression confirmed dysregulation in all expected functional categories, such as IFN signaling and keratinocyte differentiation, and allowed molecular fingerprinting of a previously characterized dendritic cell subset associated with psoriasis tumor necrosis factor alpha (TNF-α)- and inducible nitric oxide synthase (iNOS)-producing CD11bINT DC (Tip-DC). Unexpectedly, a large group of dysregulated transcripts was related to fatty acid signaling and adipocyte differentiation, exhibiting a pattern consistent with the activation of peroxisome proliferator-activated receptorδ (PPARδ). PPARδ itself was strongly induced in psoriasis in vivo. In primary keratinocytes, PPARδ was induced by the transcription factor activator protein 1, in particular by junB, but not by canonical WNT signaling, in contrast to its regulation in colon carcinoma cells. Activation of PPARδ enhanced proliferation of keratinocytes, while this was inhibited by knockdown of PPARδ. Finally, heparin-binding EGF-like growth factor (HB-EGF), known to induce epidermal hyperplasia and itself overexpressed in psoriasis, was identified as a direct target gene of PPARδ. The present data suggest that activation of PPARδ is a major event in psoriasis, contributing to the hyperproliferative phenotype by induction of HB-EGF.Journal of Investigative Dermatology (2008) 128, 110–124; doi:10.1038/sj.jid.5700943; published online 19 July 2007 [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
11. Expression of angiotensin-converting-enzyme in various cell types of human skin
- Author
-
Steckelings, U.Muscha, Hugow, Tania, Henz, Beate M., Mangoldt, Dorothea, and Artuc, Metin
- Published
- 1998
- Full Text
- View/download PDF
12. Release of Stem Cell Factor from a Human Keratinocyte Line, HaCaT, Is Increased in Differentiating <em>versus</em> Proliferating Cells.
- Author
-
Grabbe, Jürgen, Welker, Pia, Rosenbach, Thomas, Nürnberg, Wolf, Krüger-Krasagakes, Sabine, Artuc, Metin, Fiebiger, Edda, and Henz, Beate M.
- Subjects
- *
FIBROBLASTS , *MELANOCYTES , *HEMATOPOIETIC stem cells , *GROWTH factors , *IONOPHORES , *KERATINOCYTES - Abstract
Stem cell factor, a recently discovered growth factor for hematopoietic stem cells, mast cells, and melanocytes, was initially reported to be produced by fibroblasts. In this study, we investigated the secretion of this factor from human HaCaT cells during in vitro culture and compared it to synthesis by cells in the skin. Release of stem cell factor from freshly cultured keratinocytes was comparable to that of HaCaT cells and was nearly half that produced by fibroblasts and umbilical vein endothelial cells. No stem cell factor was detectable in culture supernatants of melanocytes. HaCaT cells underwent spontaneous differentiation after a period of proliferation until confluency. Depending on duration of culture, they released increasing amounts of stem cell factor (∼150 pg/106 cells on day 3 (proliferating cells) vs ∼450 pg/106 cells on day 14 (differentiating cells) measured by enzyme-linked immunosorbent assay. Stimulation for 24 h with the calcium ionophore A 23187 (10-6 to 10-8 M) further enhanced release. Western blot analysis of HaCaT cell lysates with a stem cell factor antibody revealed two proteins with the known molecular weights of membrane-bound and soluble stem cell factor. By semiquantitative reverse transcriptase polymerase chain reaction, full-length as well as spliced type stem cell factor mRNA was found to be increased in differentiating versus proliferating HaCaT cells. Keratinocytes are thus potentially important sources of stem cell factor in human skin, and HaCaT cells provide a useful model for further studies of stem cell factor from keratinocytes. [ABSTRACT FROM AUTHOR]
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.